Regeneron Pharmaceuticals
Price & Volume
Stats
See more52W Range | $475.76-$1,019.98 |
Market Cap | $59.7B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $14.2B |
Revenue Growth (YoY) | 3.6% |
Gross Profit (12 Mos) | $6.7B |
Diluted EPS | $39.70 |
News
See moreYahoo Finance • 8 hours ago
Why Apogee, A Rival To Regeneron And Sanofi, Rocketed 34% And Broke Out
Yahoo Finance • 17 hours ago
Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab
Yahoo Finance • yesterday
Regeneron gets FDA nod for squamous cell carcinoma therapy
About
CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
CFO | Mr. Christopher R. Fenimore CPA |
Address | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15,182 |
